The biopharmaceutical sector, a key player in biotechnology applications and modern pharmaceutical advancement, stands at the forefront of China’s industrial innovation. Under the “14th Five-Year Plan” and the 2035 Vision, China aims to fuse biotech with IT, boosting sectors like biopharmaceuticals and bioenergy, thereby expanding the bioeconomy. The industry, already surpassing a 4 trillion yuan market size in 2022, is projected to reach over 10 trillion yuan by 2035.

I. Time and Location:

1. Opening time: October 18, 2024 (09:00 AM)
2. Exhibition time: October 18-20, 2024

II. Organizing Institutions:

Guiding units: Tianjin Municipal People’s Government, Tianjin Municipal Bureau of Commerce, Tianjin Science and Technology Bureau, Tianjin Industrial and Information Bureau, Tianjin Education Commission

III. Expo Theme:

“Focusing on Cutting-edge Biomedical Technologies · Empowering the Innovative Development of Life Sciences”

IV. Exhibition Content:

1. Biopharmaceutical products and results
2. Biopharmaceutical ingredients
3. Biotechnology and services
4. Engineering technology equipment
5. Reagents/Consumables
6. Biopharmaceutical industrial park
7. Biopharmaceutical talent exchange

V. Fee Standards:

(A) Booths

1. Single open standard booth: 18,800 yuan (3M*3M/duration of the exhibition)
2. Double open standard booth: 19,800 yuan (3M*3M/duration of the exhibition)

VI. Forum Activities: (Tentative Invitations)

1. Biomedical Science and Technology Innovation Conference
2. Antibody Drugs and New Drug R&D Innovation Forum
3. Biopharmaceutical Industry Investment and Financing Summit Forum
4. Cell Biotechnology Summit Forum
5. Gene Therapy Technology Innovation and Openness Summit Forum
6. Biopharmaceutical Industry Digitalization Summit Forum